[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100437976":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":18,"centralContacts":23,"locations":28,"responsibleParty":41,"collaborators":10,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":10,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":10,"enrollmentInfo":52,"targetDuration":55,"studyType":56,"phases":10,"briefSummary":57,"conditions":58,"keywords":10,"overallStatus":62,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Second Affiliated Hospital, School of Medicine, Zhejiang University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Diabetes",null,"patients with diagnosed Diabetes Mellitus",[13],"Other: no intervention",[15],{"type":6,"name":16,"description":16,"armGroupLabels":17,"otherNames":10},"no intervention",[9],[19],{"name":20,"affiliation":21,"role":22},"Pengfei Shan, MD, PhD","Department of Endocrinology and Metabolism, Second Affiliated Hospital of Zhejiang University","PRINCIPAL_INVESTIGATOR",[24],{"name":20,"role":25,"phone":26,"phoneExt":10,"email":27},"CONTACT","+86 13958039665","pengfeishan@zju.edu.cn",[29],{"facility":5,"status":10,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":10},"Hangzhou","Zhejiang","310009","China","CN",{"type":36,"coordinates":37},"Point",[38,39],120.16142,30.29365,{"lat":39,"lon":38},{"type":42,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100437976","diabetes-complications-and-the-risk-of-cardiovascular-and-cerebrovascular-diseases-100437976",false,"NCT04983277","Diabetes Complications and the Risk of Cardiovascular and Cerebrovascular Diseases","Study of Diabetes Mellitus and Its Complications and the Risk of Cardiovascular and Cerebrovascular Diseases","Inclusion Criteria:\n\n* Diabetic symptoms with: plasma glucose level at any time ≥11.1mmol\u002F L (200mg\u002F dL), or Fasting plasma glucose level ≥7.0mmol\u002F L (126mg\u002F dL), or plasma glucose level ≥11.1mmol\u002F L (200ng\u002F dL) for 2 h in OGTT test, or HbA1c ≥6.5%; Or those without typical symptoms should repeated the tests in another day.\n* Han Chinese.\n* Willingness to participate.\n\nExclusion Criteria:\n\n* Secondary diabetes.\n* Participants in other clinical trials.","ALL","18 Years",{"count":53,"type":54},3000,"ESTIMATED","1 Week","OBSERVATIONAL","This study is intended to include 3000 diabetic patients in our hospital to collect complete medical history data, comprehensively improve the screening of diabetic complications and cardiovascular and cerebrovascular risk assessment.",[59,60,61],"Diabetes Complications","Cardiovascular Diseases","Cerebrovascular Disease","NOT_YET_RECRUITING","2021-07-27",{"date":65,"type":66},"2021-07-30","ACTUAL",{"date":68,"type":54},"2021-07",{"date":70,"type":54},"2030-12",{"name":5,"class":6},1]